Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis.

Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer (2012) 6.14

p53 status determines the role of autophagy in pancreatic tumour development. Nature (2013) 4.31

The dynamic nature of autophagy in cancer. Genes Dev (2011) 3.57

Autophagy in malignant transformation and cancer progression. EMBO J (2015) 2.67

Architecture of the Atg17 complex as a scaffold for autophagosome biogenesis. Cell (2012) 2.30

Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol (2012) 2.27

The role for autophagy in cancer. J Clin Invest (2015) 2.11

Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov (2013) 2.08

Functions of autophagy in normal and diseased liver. Autophagy (2013) 1.81

Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth. Nat Cell Biol (2015) 1.63

Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene (2012) 1.49

Autophagy in stem cells. Autophagy (2013) 1.43

Autophagy and cancer cell metabolism. Semin Cell Dev Biol (2012) 1.32

Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells. J Clin Invest (2013) 1.28

Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov (2014) 1.28

Staying alive: metabolic adaptations to quiescence. Cell Cycle (2012) 1.28

Interaction between FIP200 and ATG16L1 distinguishes ULK1 complex-dependent and -independent autophagy. Nat Struct Mol Biol (2012) 1.26

Emerging strategies to effectively target autophagy in cancer. Oncogene (2015) 1.26

Regulation and function of autophagy during cell survival and cell death. Cold Spring Harb Perspect Biol (2012) 1.25

FIP200 is required for maintenance and differentiation of postnatal neural stem cells. Nat Neurosci (2013) 1.25

STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious. Cancer Res (2014) 1.17

The interplay between autophagy and ROS in tumorigenesis. Front Oncol (2012) 1.17

Cellular and metabolic functions for autophagy in cancer cells. Trends Cell Biol (2014) 1.16

Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Autophagy (2014) 1.14

Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev (2016) 1.13

Risk factors for pancreatic cancer: underlying mechanisms and potential targets. Front Physiol (2014) 1.10

Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo. J Biol Chem (2012) 1.10

Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy. Proc Natl Acad Sci U S A (2015) 1.10

The complex landscape of pancreatic cancer metabolism. Carcinogenesis (2014) 1.08

Suppression of autophagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation. J Bone Miner Res (2013) 1.08

Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis. EMBO Rep (2015) 1.07

Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol (2014) 1.04

Tumor suppression and promotion by autophagy. Biomed Res Int (2014) 1.02

p62/SQSTM1 synergizes with autophagy for tumor growth in vivo. Genes Dev (2014) 1.01

Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A. Nat Commun (2015) 0.99

Targeting autophagy in breast cancer. World J Clin Oncol (2014) 0.99

ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss. Autophagy (2014) 0.98

IFNB1/interferon-β-induced autophagy in MCF-7 breast cancer cells counteracts its proapoptotic function. Autophagy (2013) 0.97

Functional role of autophagy-mediated proteome remodeling in cell survival signaling and innate immunity. Mol Cell (2014) 0.96

Autophagy in cancer. F1000Prime Rep (2015) 0.96

Autophagy, Metabolism, and Cancer. Clin Cancer Res (2015) 0.95

The importance of autophagy regulation in breast cancer development and treatment. Biomed Res Int (2014) 0.95

Mitophagy and cancer. Cancer Metab (2015) 0.95

Autophagy inhibits oxidative stress and tumor suppressors to exert its dual effect on hepatocarcinogenesis. Cell Death Differ (2014) 0.95

Androgens promote prostate cancer cell growth through induction of autophagy. Mol Endocrinol (2012) 0.95

Targeting mitochondrial metabolism by inhibiting autophagy in BRAF-driven cancers. Cancer Discov (2014) 0.94

Autophagy in breast cancer and its implications for therapy. Am J Cancer Res (2013) 0.94

HTLV-1 Tax deregulates autophagy by recruiting autophagic molecules into lipid raft microdomains. Oncogene (2013) 0.94

MDA-7/IL-24: multifunctional cancer killing cytokine. Adv Exp Med Biol (2014) 0.93

Autophagy deficiency by hepatic FIP200 deletion uncouples steatosis from liver injury in NAFLD. Mol Endocrinol (2013) 0.91

Autophagy, cell death, and cancer. Mol Cell Oncol (2015) 0.91

Autophagy in colorectal cancer: An important switch from physiology to pathology. World J Gastrointest Oncol (2015) 0.90

Paradoxical role of autophagy in the dysplastic and tumor-forming stages of hepatocarcinoma development in rats. Cell Death Dis (2013) 0.90

Protein quality control and metabolism: bidirectional control in the heart. Cell Metab (2015) 0.90

The role of autophagy induced by tumor microenvironment in different cells and stages of cancer. Cell Biosci (2015) 0.88

Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nat Rev Clin Oncol (2016) 0.88

Chloroquine and hydroxychloroquine for cancer therapy. Mol Cell Oncol (2014) 0.88

Cyclin D1 activity regulates autophagy and senescence in the mammary epithelium. Cancer Res (2012) 0.87

Recent insights into the function of autophagy in cancer. Genes Dev (2016) 0.86

Paradoxical roles of autophagy in different stages of tumorigenesis: protector for normal or cancer cells. Cell Biosci (2013) 0.86

QSOX1 inhibits autophagic flux in breast cancer cells. PLoS One (2014) 0.85

Cellular senescence and protein degradation: breaking down cancer. Cell Cycle (2014) 0.85

Deletion of autophagy inducer RB1CC1 results in degeneration of the retinal pigment epithelium. Autophagy (2015) 0.85

Metabolic, autophagic, and mitophagic activities in cancer initiation and progression. Biomed J (2016) 0.83

Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up. Cancer Discov (2015) 0.83

Pro-tumorigenic function of autophagy in mammary oncogenesis. Autophagy (2012) 0.83

Tumor cells can evade dependence on autophagy through adaptation. Biochem Biophys Res Commun (2012) 0.82

Methylation silencing of ULK2, an autophagy gene, is essential for astrocyte transformation and tumor growth. J Biol Chem (2014) 0.82

Autophagy in thyroid cancer: present knowledge and future perspectives. Front Endocrinol (Lausanne) (2015) 0.82

p27 protein protects metabolically stressed cardiomyocytes from apoptosis by promoting autophagy. J Biol Chem (2014) 0.81

MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells. Oncotarget (2015) 0.81

Autophagy in cancer metastasis. Oncogene (2016) 0.81

Tumor-promoting and -suppressive roles of autophagy in the same mouse model of BrafV600E-driven lung cancer. Cancer Discov (2013) 0.80

Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling. Cancer Res (2016) 0.79

YAP enhances autophagic flux to promote breast cancer cell survival in response to nutrient deprivation. PLoS One (2015) 0.79

Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis. Breast Cancer Res Treat (2015) 0.79

The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer. Oncotarget (2016) 0.78

Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel autophagy regulator by high content shRNA screening. Oncogene (2015) 0.78

Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling. J Biol Chem (2013) 0.78

Autophagy regulation in the development and treatment of breast cancer. Acta Biochim Biophys Sin (Shanghai) (2015) 0.77

Elevated p62/SQSTM1 determines the fate of autophagy-deficient neural stem cells by increasing superoxide. J Cell Biol (2016) 0.77

Autophagy gene expression profiling identifies a defective microtubule-associated protein light chain 3A mutant in cancer. Oncotarget (2016) 0.77

Molecular pathways: autophagy in cancer--a matter of timing and context. Clin Cancer Res (2014) 0.77

Distinct roles of autophagy-dependent and -independent functions of FIP200 revealed by generation and analysis of a mutant knock-in mouse model. Genes Dev (2016) 0.77

Autophagy and Tumor Metabolism. Cell Metab (2017) 0.77

Autophagy and tumor cell invasion. Cell Cycle (2012) 0.76

'Doubling down' on the autophagy pathway to suppress tumor growth. Genes Dev (2014) 0.76

Updates from the Intestinal Front Line: Autophagic Weapons against Inflammation and Cancer. Cells (2012) 0.76

Tumor suppression in mice lacking GABARAP, an Atg8/LC3 family member implicated in autophagy, is associated with alterations in cytokine secretion and cell death. Cell Death Dis (2016) 0.76

SIK2 Restricts Autophagic Flux To Support Triple-Negative Breast Cancer Survival. Mol Cell Biol (2016) 0.76

Hijacker of the Antitumor Immune Response: Autophagy Is Showing Its Worst Facet. Front Oncol (2016) 0.76

Autophagy protects ovarian cancer-associated fibroblasts against oxidative stress. Cell Cycle (2016) 0.76

Autophagy-Dependent Secretion: Contribution to Tumor Progression. Front Oncol (2016) 0.75

HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities. Cells (2015) 0.75

Genetic inhibition of autophagy promotes p53 loss-of-heterozygosity and tumorigenesis. Oncotarget (2016) 0.75

Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells. PLoS One (2017) 0.75

Regulation of glucose metabolism by p62/SQSTM1 through HIF1α. J Cell Sci (2016) 0.75

Transcriptional Regulation of Core Autophagy and Lysosomal Genes by the Androgen Receptor Promotes Prostate Cancer Progression. Autophagy (2016) 0.75

Autophagy, a double-edged sword in hepatocarcinogenesis. Mol Cell Oncol (2015) 0.75

Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy. BMC Cancer (2016) 0.75

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52

Hallmarks of cancer: the next generation. Cell (2011) 140.01

The hallmarks of cancer. Cell (2000) 113.05

Autophagy in the pathogenesis of disease. Cell (2008) 34.68

Autophagy fights disease through cellular self-digestion. Nature (2008) 33.83

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54

Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature (2006) 24.39

Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature (1999) 23.62

Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature (2006) 21.40

Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol (2005) 18.60

Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest (2003) 16.67

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med (2003) 16.62

Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A (2003) 15.59

Autophagy: process and function. Genes Dev (2007) 15.21

Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol (2002) 14.75

Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell (2007) 14.63

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol (1992) 12.96

Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell (2006) 11.79

Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol (2005) 11.57

Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature (2008) 11.39

Network organization of the human autophagy system. Nature (2010) 11.38

Autophagy and the integrated stress response. Mol Cell (2010) 11.21

Autophagy in immunity and inflammation. Nature (2011) 11.16

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 11.03

Principles of cancer therapy: oncogene and non-oncogene addiction. Cell (2009) 10.96

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A (2005) 10.89

Role of autophagy in cancer. Nat Rev Cancer (2007) 10.88

A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature (2008) 10.84

Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer (2005) 10.06

Autophagy suppresses tumorigenesis through elimination of p62. Cell (2009) 9.95

Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol (2006) 9.42

The immunobiology of cancer immunosurveillance and immunoediting. Immunity (2004) 9.39

Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest (2007) 9.33

ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell (2009) 9.24

Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct (1998) 9.18

Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell (2009) 9.14

TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol (2008) 8.95

Eaten alive: a history of macroautophagy. Nat Cell Biol (2010) 8.83

The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med (2007) 8.82

Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol (2003) 8.61

Interferons, immunity and cancer immunoediting. Nat Rev Immunol (2006) 8.23

Adaptive immunity maintains occult cancer in an equilibrium state. Nature (2007) 8.14

Autophagy and metabolism. Science (2010) 8.10

Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev (2011) 7.43

FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J Cell Biol (2008) 7.16

Autophagy mediates the mitotic senescence transition. Genes Dev (2009) 6.80

Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell (2010) 6.79

Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev (2007) 6.35

ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem (2009) 6.34

Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov (2007) 6.33

Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics (1999) 6.23

Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab (2008) 5.55

The double-edged sword of autophagy modulation in cancer. Clin Cancer Res (2009) 5.46

Stromal effects on mammary gland development and breast cancer. Science (2002) 5.22

Cancer immunology. N Engl J Med (2008) 5.22

Immune surveillance of tumors. J Clin Invest (2007) 5.04

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood (2009) 4.80

A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans (2009) 4.37

PRAK is essential for ras-induced senescence and tumor suppression. Cell (2007) 4.30

Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol (1997) 4.27

Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol (2004) 3.95

Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ (2006) 3.95

The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci U S A (2007) 3.93

Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci U S A (2009) 3.84

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol (2007) 3.81

Autophagy genes in immunity. Nat Immunol (2009) 3.76

Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes. J Cell Biol (2009) 3.71

Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell (2010) 3.63

Decoding cell death signals in inflammation and immunity. Cell (2010) 3.41

T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol (2010) 3.39

Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo. Proc Natl Acad Sci U S A (2009) 2.95

Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J Cell Biol (2005) 2.75

Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy (2010) 2.62

IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity (2000) 2.58

Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. J Immunol (2007) 2.21

Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med (2002) 2.17

Role of FIP200 in cardiac and liver development and its regulation of TNFalpha and TSC-mTOR signaling pathways. J Cell Biol (2006) 2.12

Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity (2009) 2.11

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? Curr Opin Immunol (2007) 2.05

Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res (2009) 2.04

Inhibition of paraquat-induced autophagy accelerates the apoptotic cell death in neuroblastoma SH-SY5Y cells. Toxicol Sci (2007) 1.87

Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell (2008) 1.80

FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells. Blood (2010) 1.78

Sumoylation delimits KLF8 transcriptional activity associated with the cell cycle regulation. J Biol Chem (2006) 1.67

Impaired interferon signaling is a common immune defect in human cancer. Proc Natl Acad Sci U S A (2009) 1.66

FIP200, a key signaling node to coordinately regulate various cellular processes. Cell Signal (2007) 1.64

Truncating mutations of RB1CC1 in human breast cancer. Nat Genet (2002) 1.60

Suppression of Pyk2 kinase and cellular activities by FIP200. J Cell Biol (2000) 1.47

Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol Biol Cell (2002) 1.46

Autophagy genes as tumor suppressors. Curr Opin Cell Biol (2009) 1.44

Role of ULK-FIP200 complex in mammalian autophagy: FIP200, a counterpart of yeast Atg17? Autophagy (2009) 1.42

Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control. J Cell Biol (2005) 1.39

Neural-specific deletion of FIP200 leads to cerebellar degeneration caused by increased neuronal death and axon degeneration. J Biol Chem (2009) 1.38

Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. Cancer Res (2005) 1.36

Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. Oncogene (2002) 1.35

Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells. J Exp Med (2007) 1.28

Autophagy and tumorigenesis. Semin Immunopathol (2010) 1.26

Inhibition of autophagy potentiates sulforaphane-induced apoptosis in human colon cancer cells. Ann Surg Oncol (2009) 1.11

The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells. Cell Growth Differ (2000) 1.10

Inactivation of FIP200 leads to inflammatory skin disorder, but not tumorigenesis, in conditional knock-out mouse models. J Biol Chem (2008) 1.07

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med (2004) 22.96

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc (2007) 12.39

Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell (2009) 9.14

Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 7.36

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med (2003) 7.35

FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J Cell Biol (2008) 7.16

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood (2009) 4.80

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest (2010) 4.22

Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood (2009) 4.13

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol (2007) 3.81

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med (2006) 3.75

Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev (2009) 3.47

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol (2008) 3.22

Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc Natl Acad Sci U S A (2007) 3.10

Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J Cell Biol (2005) 2.75

PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell (2010) 2.68

Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its nuclear-binding partners. Nat Cell Biol (2006) 2.52

Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol (2006) 2.50

CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res (2005) 2.38

Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol (2006) 2.36

Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res (2004) 2.28

Wound-healing assay. Methods Mol Biol (2005) 2.28

Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology (2009) 2.22

Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev (2010) 2.21

Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. J Immunol (2007) 2.21

Role of FIP200 in cardiac and liver development and its regulation of TNFalpha and TSC-mTOR signaling pathways. J Cell Biol (2006) 2.12

Identification of transcription factor KLF8 as a downstream target of focal adhesion kinase in its regulation of cyclin D1 and cell cycle progression. Mol Cell (2003) 2.09

Biochemistry and biomechanics of cell motility. Annu Rev Biomed Eng (2005) 2.08

Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice. Endocrinology (2011) 2.07

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res (2005) 2.06

Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Int J Cancer (2011) 2.05

Cool-1 functions as an essential regulatory node for EGF receptor- and Src-mediated cell growth. Nat Cell Biol (2006) 2.04

Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res (2009) 2.04

The role of the dynamics of focal adhesion kinase in the mechanotaxis of endothelial cells. Proc Natl Acad Sci U S A (2002) 2.01

Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res (2007) 2.01

Human TH17 cells are long-lived effector memory cells. Sci Transl Med (2011) 1.99

Regulatory T cells in ovarian cancer: biology and therapeutic potential. Am J Reprod Immunol (2005) 1.96

Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice. Cardiovasc Res (2004) 1.93

Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell (2012) 1.91

Activation of FAK and Src are receptor-proximal events required for netrin signaling. Nat Neurosci (2004) 1.89

Regulatory T-cell compartmentalization and trafficking. Blood (2006) 1.86

VEGF-induced vascular permeability is mediated by FAK. Dev Cell (2012) 1.85

T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Curr Opin Immunol (2013) 1.79

The LC3 recruitment mechanism is separate from Atg9L1-dependent membrane formation in the autophagic response against Salmonella. Mol Biol Cell (2011) 1.79

FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells. Blood (2010) 1.78

Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity (2013) 1.77

IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J Immunol (2011) 1.76

Deciphering the role of Th17 cells in human disease. Trends Immunol (2011) 1.76

Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell (2012) 1.75

Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK. J Cell Biol (2008) 1.74

From the Cover: Neutralization of terminal differentiation in gliomagenesis. Proc Natl Acad Sci U S A (2013) 1.71

Focal adhesion kinase regulation of N-WASP subcellular localization and function. J Biol Chem (2003) 1.70

Sumoylation delimits KLF8 transcriptional activity associated with the cell cycle regulation. J Biol Chem (2006) 1.67

The Scottish Structural Proteomics Facility: targets, methods and outputs. J Struct Funct Genomics (2010) 1.66

Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer Res (2007) 1.66

FIP200, a key signaling node to coordinately regulate various cellular processes. Cell Signal (2007) 1.64

Th17 cells in cancer: help or hindrance? Carcinogenesis (2011) 1.63

FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res (2009) 1.63

FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation. Dev Cell (2005) 1.62

Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice. J Clin Invest (2005) 1.61

Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett (2009) 1.59

A novel interference mechanism by a type IIIB CRISPR-Cmr module in Sulfolobus. Mol Microbiol (2013) 1.58

AFV1, a novel virus infecting hyperthermophilic archaea of the genus acidianus. Virology (2003) 1.56

Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase. Role of Rho family small GTPases. J Biol Chem (2004) 1.52

Regulation of focal adhesion kinase by its amino-terminal domain through an autoinhibitory interaction. Mol Cell Biol (2003) 1.51

Systematic deletion analysis of fission yeast protein kinases. Eukaryot Cell (2005) 1.51

FoxO family members in cancer. Cancer Biol Ther (2011) 1.49

p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain. J Biol Chem (2004) 1.48

Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice. Proc Natl Acad Sci U S A (2008) 1.48

Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology (2012) 1.47

Autophagy proteins control goblet cell function by potentiating reactive oxygen species production. EMBO J (2013) 1.47

Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol Biol Cell (2002) 1.46

Role of kinase-independent and -dependent functions of FAK in endothelial cell survival and barrier function during embryonic development. J Cell Biol (2010) 1.44

Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin. J Cell Biol (2013) 1.44

FAK-MAPK-dependent adhesion disassembly downstream of L1 contributes to semaphorin3A-induced collapse. EMBO J (2008) 1.42

Mechanisms of focal adhesion kinase regulation. Curr Cancer Drug Targets (2005) 1.40

Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control. J Cell Biol (2005) 1.39

Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Cancer Res (2009) 1.39